Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex

Molecular Brain Research

Volumn 42, Issue 1, 1996, Pages 175-178

  Fahnestock, Margaret ^a   Scott, Samuel A ^b,c   Jetté, Nathalie ^a   Weingartner, Jean A ^b   Crutcher, Keith A ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c BARRY UNIVERSITY   (United States)

Author keywords

Basal forebrain; Dot blots; ELISA; Nerve growth factor; Neurodegeneration; Neurotrophic factor; Retrograde transport

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PARIETAL LOBE; PRIORITY JOURNAL;

EID: 0030297659     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00193-3     Document Type: Article

References (17)

1. [1] Allen, S.J., MacGowan, S.H., Treanor, J.S., Feeney, R., Wilcock, G.K. and Dawbarn, D., Normal β-NGF content in Alzheimer's disease cerebral cortex and hippocampus, Neurosci. Lett., 131 (1991) 135-139.
2. [2] Crutcher, K.A., Scott, S.A., Liang, S., Everson, W.V. and Weingartner, J., Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease, J. Neurosci., 13 (1993) 2540-2550.
3. [3] Gasser, U.E., Weskamp, G., Otten, U. and Dravid, A.R., Time course of the elevation of nerve growth factor (NGF) content in the hippocampus and septum following lesions of the septo-hippocampal pathway in rats, Brain Res., 376 (1986) 351-356.
4. [4] Goedert, M., Fine, A., Hunt, S.P. and Ullrich, A., Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease, Mol. Brain Res., 1 (1986) 85-92.
5. [5] Harrison, P.J., Barton, A.J.L., Najlerahim, A., McDonald, B. and Pearson, R.C.A., Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer's disease, Psychol. Med., 21 (1991) 855-866.
6. [6] Hefti, F. and Weiner, W.J., Nerve growth factor and Alzheimer's disease, Ann. Neurol., 20 (1986) 275-281.
7. [7] Jetté, N., Cole, M.S. and Fahnestock, M., NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients, Mol. Brain Res., 25 (1994) 242-250.
8. [8] Johnson, S.A., Morgan, D.G. and Finch, C.E., Extensive postmortem stability of RNA from rat and human brain, J. Neurosci. Res., 16 (1986) 267-280.
9. [9] Khatchaturian, Z.S., Diagnosis of Alzheimer's disease, Arch. Neurol., 42 (1985) 1097-1105.
10. NGF content, Neurosci. Lett., 66 (1986) 175-180.
11. [11] McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34 (1984) 939-944.
12. [12] Mufson, E.J., Conner, J.M. and Kordower, J.H., Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis, NeuroReport, 6 (1995) 1063-1066.
13. [13] Murase, K., Nabeshima, T., Robitaille, Y., Quirion, R., Ogawa, M. and Hayashi, K., NGF level is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease, Biochem. Biophys. Res. Commun., 193 (1993) 198-203.
14. [14] Price, D.L., New perspectives on Alzheimer's disease, Annu. Rev. Neurosci., 9 (1986) 489-512.
15. [15] Scott, S.A. and Crutcher, K.A., Nerve growth factor and Alzheimer's disease, Rev. Neurosci., 5 (1994) 179-211.
16. [16] Scott, S.A., Mufson, E.J., Weingartner, J.A., Skau, K.A. and Crutcher, K.A., Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis, J. Neurosci., 15 (1995) 6213-6221.
17. [17] Taylor, G.R., Carter, G.I., Crow, T.J., Johnson, J.A., Fairbairn, A.F., Perry, E.K. and Perry, R.H., Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization, Exp. Mol. Pathol., 44 (1986) 111-116.